naxitamab
y-mabs therapeutics
['naxitamab', 'breast']
excited to present our data demonstrating naxitamab, a humanized anti-gd2 antibody, inhibits gd2 mediated immunosuppression in breast cancer. #aacr2023 #aacr 
Research fellow at MD Anderson, TX. Interested in Tumor-Immunology; busy in finding contentment personally/professionally. 🇮🇳🇺🇸